Genentech, University of Cambridge and Babraham Bioscience Technologies have backed accelerator Start Codon, which plans to work with some 50 life sciences startups.
Genentech, a biotech subsidiary of pharmaceutical firm Roche, has co-founded a UK-based life sciences accelerator called Start Codon that will invest in up to 50 seed-stage startups over the next five years.
The co-founders also include Cambridge Innovation Capital (CIC), the patient capital fund established by University of Cambridge, and Babraham Bioscience Technologies, which manages the bioscience-focused Babraham Research Campus, as well as private backers Jonathan Milner and Ian Tomlinson.
Start Codon will nurture pre-series A companies that extend life…
